FOTIVDA (TIVOZANIB )
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 19 Oct 2022)
What this means for you
Registered since 03 May 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 85849026
- Registration number
- 4951641
- Mark type
- Design + words
- Filed
- 13 Feb 2013
- Published for opposition
- 14 May 2013
- Registered
- 03 May 2016
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, namely, pharmaceutical preparations containing tivozanib hydrochloride
Owner
- AVEO Pharmaceuticals, Inc., Boston, MA, US
- AVEO Pharmaceuticals, Inc., Cambridge, MA, US
- AVEO Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 13 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 13 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 May 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jun 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Nov 2022 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 19 Oct 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Oct 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Oct 2022 — AMENDMENT UNDER SECTION 7 - PROCESSED